284 related articles for article (PubMed ID: 28315335)
1. MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.
Zhang ZW; Guo RW; Lv JL; Wang XM; Ye JS; Lu NH; Liang X; Yang LX
Biochem Biophys Res Commun; 2017 Apr; 486(2):414-422. PubMed ID: 28315335
[TBL] [Abstract][Full Text] [Related]
2. MiR-137 inhibited cell proliferation and migration of vascular smooth muscle cells via targeting IGFBP-5 and modulating the mTOR/STAT3 signaling.
Pan J; Li K; Huang W; Zhang X
PLoS One; 2017; 12(10):e0186245. PubMed ID: 29016699
[TBL] [Abstract][Full Text] [Related]
3. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-761 inhibits Angiotensin II-induced vascular smooth muscle cell proliferation and migration by targeting mammalian target of rapamycin.
Cho JR; Lee CY; Lee J; Seo HH; Choi E; Chung N; Kim SM; Hwang KC; Lee S
Clin Hemorheol Microcirc; 2015 Sep; 63(1):45-56. PubMed ID: 26444612
[TBL] [Abstract][Full Text] [Related]
6. miR-503 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting the insulin receptor.
Bi R; Ding F; He Y; Jiang L; Jiang Z; Mei J; Liu H
Biomed Pharmacother; 2016 Dec; 84():1711-1716. PubMed ID: 27829550
[TBL] [Abstract][Full Text] [Related]
7. [Effects of rosuvastatin in homocysteine induced mouse vascular smooth muscle cell dedifferentiation and endoplasmic reticulum stress and its mechanisms].
Zhou CZ; Pan SL; Lin H; Meng LP; Ji Z; Chi JF; Guo HY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):43-48. PubMed ID: 29926658
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-217 suppresses homocysteine-induced proliferation and migration of vascular smooth muscle cells via N-methyl-D-aspartic acid receptor inhibition.
Duan H; Li Y; Yan L; Yang H; Wu J; Qian P; Li B; Wang S
Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):967-75. PubMed ID: 27333430
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145 alleviates high glucose-induced proliferation and migration of vascular smooth muscle cells through targeting ROCK1.
Chen M; Zhang Y; Li W; Yang J
Biomed Pharmacother; 2018 Mar; 99():81-86. PubMed ID: 29324316
[TBL] [Abstract][Full Text] [Related]
10. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway.
Zhang M; Li F; Wang X; Gong J; Xian Y; Wang G; Zheng Z; Shang C; Wang B; He Y; Wang W; Lin R
Histochem Cell Biol; 2020 May; 153(5):357-366. PubMed ID: 32124010
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway.
Wu YT; Bi YM; Tan ZB; Xie LP; Xu HL; Fan HJ; Chen HM; Li J; Liu B; Zhou YC
Eur J Pharmacol; 2019 Jun; 853():93-102. PubMed ID: 30878387
[TBL] [Abstract][Full Text] [Related]
12. Loss of canonical insulin signaling accelerates vascular smooth muscle cell proliferation and migration through changes in p27Kip1 regulation.
Lightell DJ; Moss SC; Woods TC
Endocrinology; 2011 Feb; 152(2):651-8. PubMed ID: 21190963
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
Oneyama C; Ikeda J; Okuzaki D; Suzuki K; Kanou T; Shintani Y; Morii E; Okumura M; Aozasa K; Okada M
Oncogene; 2011 Aug; 30(32):3489-501. PubMed ID: 21383697
[TBL] [Abstract][Full Text] [Related]
14. MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.
Huang HG; Luo X; Wu S; Jian B
Asian Pac J Cancer Prev; 2015; 16(12):4937-44. PubMed ID: 26163618
[TBL] [Abstract][Full Text] [Related]
15. miR-379 Inhibits Cell Proliferation, Invasion, and Migration of Vascular Smooth Muscle Cells by Targeting Insulin-Like Factor-1.
Li K; Wang Y; Zhang A; Liu B; Jia L
Yonsei Med J; 2017 Jan; 58(1):234-240. PubMed ID: 27873518
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
Li D; Liu X; Lin L; Hou J; Li N; Wang C; Wang P; Zhang Q; Zhang P; Zhou W; Wang Z; Ding G; Zhuang SM; Zheng L; Tao W; Cao X
J Biol Chem; 2011 Oct; 286(42):36677-85. PubMed ID: 21878637
[TBL] [Abstract][Full Text] [Related]
17. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor.
Song L; Duan P; Guo P; Li D; Li S; Xu Y; Zhou Q
Arch Biochem Biophys; 2012 Dec; 528(2):204-11. PubMed ID: 23046980
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis.
Gao S; Wassler M; Zhang L; Li Y; Wang J; Zhang Y; Shelat H; Williams J; Geng YJ
Atherosclerosis; 2014 Jan; 232(1):171-9. PubMed ID: 24401233
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L
Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
